Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.635
+0.025 (0.69%)
Apr 20, 2026, 1:25 PM EDT - Market open
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.14 billion as of April 20, 2026. Its market cap has decreased by -58.98% in one year.
Market Cap
1.14B
Enterprise Value
2.41B
1-Year Change
-58.98%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.14B, an increase of 273.44%. That is a compound annual growth rate of 27.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.13B | -29.63% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ANI Pharmaceuticals | 1.84B |
| Perrigo Company | 1.62B |
| Harrow | 1.55B |
| Evotec SE | 1.18B |
| Collegium Pharmaceutical | 1.12B |
| Amphastar Pharmaceuticals | 1.04B |
| Cronos Group | 1.03B |
| Pacira BioSciences | 1.00B |